Vanguard Group
CANO

Vanguard Group’s Cano Health, Inc. CANO Stock Holding History

Vanguard Group’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-125,122
Closed -$734K – 4554
2023
Q4 		$734K Sell
125,122
-60,560
-33% -$717K ﹤0.01% 3919
2023
Q3 		$4.71M Sell
185,682
-52,718
-22% -$4.33M ﹤0.01% 3275
2023
Q2 		$33.1M Buy
238,400
+73,076
+44% +$9.38M ﹤0.01% 2371
2023
Q1 		$15M Buy
165,324
+3,448
+2% +$468K ﹤0.01% 2733
2022
Q4 		$22.2M Buy
161,876
+15,055
+10% +$5.1M ﹤0.01% 2574
2022
Q3 		$127M Sell
146,821
-11,527
-7% -$7.23M ﹤0.01% 1651
2022
Q2 		$69.4M Buy
158,348
+31,055
+24% +$16.2M ﹤0.01% 2025
2022
Q1 		$80.8M Buy
127,293
+5,938
+5% +$3.74M ﹤0.01% 2057
2021
Q4 		$108M Buy
121,355
+708
+0.6% +$744K ﹤0.01% 1945
2021
Q3 		$153M Buy
+120,647
New +$146M ﹤0.01% 1752

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Vanguard Group's CANO Position: Q1 2024 in Review

Vanguard Group sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 125,122 shares — an estimated $734K sold.

Vanguard Group first reported a position in CANO in Q3 2021 and held it in 10 quarters. The position peaked at $153M in Q3 2021. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Vanguard Group reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Vanguard Group sold 125,122 Cano Health, Inc. shares in Q1 2024, an estimated $734K.
  • Vanguard Group first reported a position in Cano Health, Inc. in Q3 2021 and held it in 10 quarters.
  • Vanguard Group's Cano Health, Inc. position peaked at $153M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.